Furthermore, CB activation could interfere with breast cancer bone metastasis via C-X-C motif chemokine ligand 12 (CXCL12) and C-X-C motif chemokine receptor 4 (CXCR4) pathway [49, 50]. Here, CXCR4 is linked to breast cancer.